Moller Wealth Partners’s AbbVie ABBV Stock Holding History

Moller Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$643K	Buy	+2,554	New	+$549K	0.12%	42
2019 Q2	–	Sell	-7,126	Closed	-$604K	–	51
2019 Q1	$604K	Hold	7,126	–	–	0.27%	33
2018 Q4	$604K	Buy	+7,126	New	+$627K	0.39%	38
2017 Q4	–	Sell	-3,493	Closed	-$253K	–	48
2017 Q3	$253K	Hold	3,493	–	–	0.1%	39
2017 Q2	$253K	Buy	+3,493	New	+$235K	0.11%	39
2014 Q4	–	Sell	-7,522	Closed	-$434K	–	44
2014 Q3	$434K	Hold	7,522	–	–	0.2%	38
2014 Q2	$425K	Hold	7,522	–	–	0.19%	40
2014 Q1	$387K	Buy	7,522 +3,493	+87%	+$177K	0.2%	39
2013 Q4	$213K	Buy	+4,029	New	+$198K	0.11%	45

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Moller Wealth Partners's ABBV Position: Q2 2026 in Review

Moller Wealth Partners opened a new position in AbbVie (ABBV) in Q2 2026: 2,554 shares worth $643K. The stake represents 0.12% of the portfolio and ranks #42 among its holdings. This is a return to the name: Moller Wealth Partners previously reported a position in ABBV as recently as Q1 2019.

Moller Wealth Partners first reported a position in ABBV in Q4 2013 and has held it in 9 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Moller Wealth Partners held 2,554 shares of AbbVie worth $643K as of Q2 2026.
AbbVie was a new Moller Wealth Partners position in Q2 2026.
AbbVie made up 0.12% of Moller Wealth Partners's portfolio in Q2 2026, its #42 holding.
Moller Wealth Partners first reported a position in AbbVie in Q4 2013 and has held it in 9 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Moller Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.